Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 13,763 shares at $251.18 ($3.4M) on 2020-11-04, disclosed to the SEC on 2020-11-05.
Open-market sale of $3.4M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 285 | $0 | 0.0% |
| 2 | $249.09 | 2,639 | $657K | 19.5% |
| 3 | $249.09 | 2,639 | $657K | 19.5% |
| 4 | $250.23 | 580 | $145K | 4.3% |
| 5 | $250.23 | 580 | $145K | 4.3% |
| 6 | $251.18 | 3,520 |
| $884K |
| 26.2% |
| 7 | $251.18 | 3,520 | $884K | 26.2% |
| Total | $245.10 avg | 13,763 | $3.4M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |